Germline genetic association on efficacy of Immune-checkpoint inhibition in Metastatic Melanoma patients

被引：0
|
作者：
Ouwerkerk, W. [1 ]
Chielie, S. [1 ]
Bekkenk, M. [1 ]
Van Doorn, R. [2 ]
Blank, C. U. [3 ]
Haanen, J. B. [3 ]
Hospers, G. A. [4 ]
Kirchhoff, T. [5 ]
Luiten, R. [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
[2] LUMC, Leiden, Netherlands
[3] NKI, Amsterdam, Netherlands
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] NYU Langone Hlth, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
485
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [21] Immune-checkpoint inhibition for digestive cancers
    Manfredi, Sylvain
    Drouillard, Antoine
    LANCET ONCOLOGY, 2017, 18 (05): : 561 - 562
  • [22] RNA Splicing and Immune-Checkpoint Inhibition
    Ding, Li
    Odunsi, Kunle
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (19): : 1807 - 1809
  • [23] Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients.
    Rodriguez, Benigno
    Martinez-Herrera, Jose Fabian
    Zepeda, Lorena Lopez
    Olivares, Guillermo
    Villalobos, Alberto
    Perez, Fernando
    Limas, Christian Patricio Camacho
    Serrano, Juan Alberto
    Villamayor, Omar Serrano
    Lopez, Ervin Saul Enciso
    Gerson, Daniela Shveid
    Sanchez, Efrain Isaias Camarin
    Molina, Diana Bonilla
    Cabrera, Juan Manuel Tovar
    Nehmad, Cecilia
    Whaley, Juan Jose Juarez -Vignon
    Gerson, Raquel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
    Melzer, Yasmin F.
    Fergen, Nadine L.
    Mess, Christian
    Stadler, Julia-Christina
    Geidel, Glenn
    Schwietzer, Ysabel A.
    Pantel, Klaus
    Schneider, Stefan W.
    Utikal, Jochen
    Wladykowski, Ewa
    Vidal-y-Sy, Sabine
    Bauer, Alexander
    Gebhardt, Christoffer
    TRANSLATIONAL ONCOLOGY, 2025, 52
  • [25] Interferon enhances immune-checkpoint inhibition
    Romero D.
    Nature Reviews Clinical Oncology, 2019, 16 (1) : 6 - 6
  • [26] Investigation of the immune infiltrate of metastatic melanoma under immune checkpoint inhibition
    Hassel, J. C.
    Flossdorf, M.
    Haenzelmann, S.
    Winkler, J.
    Appel, L.
    Streit, E.
    Halama, N.
    Faryna, M.
    Poschke, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S244 - S244
  • [27] Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma
    Scovell, Jason M.
    Benz, Karl
    Samarska, Iryna
    Kohn, Taylor P.
    Hooper, Jody E.
    Matoso, Andres
    Herati, Amin S.
    JAMA ONCOLOGY, 2020, 6 (08) : 1297 - 1299
  • [28] INTRACRANIAL OUTCOMES OF DUAL IMMUNE-CHECKPOINT INHIBITION AND SRS COMBINATION IN PATIENTS WITH MELANOMA AND NSCLC BRAIN METASTASES
    Vaios, Eugene
    Shenker, Rachel
    Hendrickson, Peter
    Wan, Zihan
    Niedzwiecki, Donna
    Winter, Sebastian F.
    Dietrich, Jorg
    Salama, April
    Clarke, Jeffrey
    Allen, Karen
    Mullikin, Trey
    Floyd, Scott
    Kirkpatrick, John
    Reitman, Zachary
    NEURO-ONCOLOGY, 2023, 25
  • [29] Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma
    Reitmajer, Markus
    Livingstone, Elisabeth
    Thoms, Kai-Martin
    Heppt, Markus V.
    Meiss, Frank
    Gesierich, Anja
    Drexler, Konstantin
    Heinzerling, Lucie
    Meier, Friedegund
    Menzer, Christian
    Schlaak, Max
    Zimmer, Lisa
    Forschner, Andrea
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23 (03): : 329 - 329
  • [30] Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis
    Pham, James P.
    On, Lawrence
    Ardolino, Luke
    Hurwitz, Joshua
    Salaun, Helene
    Sim, Hao-Wen
    Joshua, Anthony M.
    MELANOMA RESEARCH, 2023, 33 (04) : 316 - 325
12345